116 related articles for article (PubMed ID: 2544437)
1. Changes of dipeptidyl peptidase (DP IV) activity in the T lymphocytes of rats following administration of ACTH, dexamethasone and opiates.
Korányi L; Walentin S; Hepp J; Endröczi E
Exp Clin Endocrinol; 1989 Apr; 93(1):61-8. PubMed ID: 2544437
[TBL] [Abstract][Full Text] [Related]
2. Naloxone-insensitive modulation of gastric acid output by [D-Met2,Pro5]enkephalinamide in rats.
Till M; Szombath D; Gáti T; Székely JI
Eur J Pharmacol; 1990 Jan; 175(3):355-8. PubMed ID: 2323351
[TBL] [Abstract][Full Text] [Related]
3. Action of enkephalin analogues and morphine on brain acetylcholine release: differential reversal by naloxone and an opiate pentapeptide.
Jhamandas K; Sutak M
Br J Pharmacol; 1980; 71(1):201-10. PubMed ID: 7470736
[TBL] [Abstract][Full Text] [Related]
4. Effect of [D-Met2,Pro5]enkephalinamide on gastric ulceration and transmucosal potential difference.
Till M; Gáti T; Rábai K; Szombath D; Székely JI
Eur J Pharmacol; 1988 Jun; 150(3):325-30. PubMed ID: 3416913
[TBL] [Abstract][Full Text] [Related]
5. Superoxide dismutase activity in thymus cell suspension: effects of methionine-enkephalin and morphine.
Endröczi E; Sasváry M; Walentin S; Lévay G; Korányi L; Kovács Z
Biomed Biochim Acta; 1988; 47(12):1007-11. PubMed ID: 3267083
[TBL] [Abstract][Full Text] [Related]
6. Dipeptidyl peptidase IV (DP IV), a functional marker of the T lymphocyte system.
Ansorge S; Schön E
Acta Histochem; 1987; 82(1):41-6. PubMed ID: 2892340
[TBL] [Abstract][Full Text] [Related]
7. ACTH and corticosterone response to naloxone and morphine in normal, hypophysectomized and dexamethasone-treated rats.
Jezová D; Vigas M; Jurcovicová J
Life Sci; 1982 Jul; 31(4):307-14. PubMed ID: 6292645
[TBL] [Abstract][Full Text] [Related]
8. Investigations on the effects of long-term administration of a methionine-enkephalin analogue on the adrenal zona fasciculata of rats treated with dexamethasone or dexamethasone and ACTH.
Mazzocchi G; Robba C; Rebuffat P; Gottardo G; Nussdorfer GG
J Steroid Biochem; 1986 Oct; 25(4):535-40. PubMed ID: 3022077
[TBL] [Abstract][Full Text] [Related]
9. Thermoregulatory effects of D-met2-pro5-enkephalinamide.
Szikszay M; Benedek G; Székely JI
Neuropeptides; 1983 Oct; 3(6):465-75. PubMed ID: 6686654
[TBL] [Abstract][Full Text] [Related]
10. The Met-enkephalin analog D-Ala2-Met-enkephalinamide decreases the adrenocortical response to ACTH in dispersed rat adrenal cells.
Guaza C; Borrell J
Peptides; 1984; 5(5):895-7. PubMed ID: 6095218
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of a potent opioid peptide, (D-Met2, Pro5)-enkephalinamide.
Jaszlits L; Kósa E; Tardos L; Danitz B; Kauthny K; Székely JI
Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):91-103. PubMed ID: 7165424
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase IV (DP IV) and superoxide dismutase activity in thymus-derived lymphocytes: effects of inhibitory peptides and Zn2+ in vitro.
Endröczi E; Hepp J; Sasváry M; Walentin S; Lévay G
Acta Physiol Hung; 1990; 75(1):35-44. PubMed ID: 1971138
[TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase IV and alpha-naphthylacetate esterase in human T lymphocytes: cytochemical and biochemical investigations.
Schön E; Ittenson A; Klemm K; Ansorge S
Acta Histochem; 1984; 75(2):175-82. PubMed ID: 6151772
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase IV in human T lymphocytes. Impaired induction of interleukin 2 and gamma interferon due to specific inhibition of dipeptidyl peptidase IV.
Schön E; Demuth HU; Eichmann E; Horst HJ; Körner IJ; Kopp J; Mattern T; Neubert K; Noll F; Ulmer AJ
Scand J Immunol; 1989 Feb; 29(2):127-32. PubMed ID: 2564215
[TBL] [Abstract][Full Text] [Related]
15. Mesencephalic sites of action of an enkephalin analogue (D-Met2, Pro5)-enkephalinamide and naloxone on the anterior pituitary of male rats.
Molnár J; Halász B
Brain Res; 1991 Nov; 563(1-2):270-2. PubMed ID: 1786539
[TBL] [Abstract][Full Text] [Related]
16. Diurnal variation in prolactin, adrenocorticotropin and corticosterone release induced by opiate agonists in intact and adrenalectomized rats.
Kiem DT; Kanyicska B; Stark E; Fekete MI
Neuroendocrinology; 1987 Dec; 46(6):475-80. PubMed ID: 2892145
[TBL] [Abstract][Full Text] [Related]
17. Naloxone inhibits both glucocorticoid and [D-Ala2,Met5]enkephalinamide reversal of behavioural effect of adrenalectomy.
Jefferys D; Copolov D; Funder JW
Eur J Pharmacol; 1984 Aug; 103(3-4):205-10. PubMed ID: 6489441
[TBL] [Abstract][Full Text] [Related]
18. Naloxone inhibits and morphine potentiates the adrenal steroidogenic response to ACTH.
Heybach JP; Vernikos J
Eur J Pharmacol; 1981 Oct; 75(1):1-6. PubMed ID: 6274654
[TBL] [Abstract][Full Text] [Related]
19. Dipeptidyl peptidase IV in the immune system. Cytofluorometric evidence for induction of the enzyme on activated T lymphocytes.
Schön E; Ansorge S
Biol Chem Hoppe Seyler; 1990 Aug; 371(8):699-705. PubMed ID: 1698386
[TBL] [Abstract][Full Text] [Related]
20. Differences in hypothalamo-pituitary-adrenocortical activity in the rat after acute and prolonged treatment with morphine.
Buckingham JC; Cooper TA
Neuroendocrinology; 1984 May; 38(5):411-7. PubMed ID: 6328347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
